/SQL
SQL Stock - SeqLL Inc.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$6.60-2.38%
$0.16 (-2.38%) • Jan 16
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.69
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $7.26
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SQL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.53 – $6.67
TARGET (TP)$7.59
STOP LOSS$6.07
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.29
52W High$8.20
52W Low$6.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $442.61M | $1,177 | $48,021 | $50,588 | $160,480 |
| Gross Profit | $47.18M | $487 | $-9,669 | $-120,215 | $-59,283 |
| Gross Margin | 10.7% | 41.4% | -20.1% | -237.6% | -36.9% |
| Operating Income | $-21,834,592 | $-3,997,148 | $-2,548,628 | $-949,722 | $-2,291,299 |
| Net Income | $-135,479,890 | $-4,192,518 | $-3,906,078 | $-1,524,116 | $-2,655,799 |
| Net Margin | -30.6% | -356203.7% | -8134.1% | -3012.8% | -1654.9% |
| EPS | $-3.68 | $-14.11 | $-21.65 | $-12.53 | $-21.84 |
Company Overview
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SQLBeat Rate
0%
Last 2 quarters
Avg Surprise
-2646.2%
EPS vs Estimate
Beats / Misses
0/2
Last 12 quarters
Latest EPS
$-1.96
Q2 2024
EPS Surprise History
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
-5100.0%
$-4.00vs$0.08
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 30, 2024 | — | $-1.96 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-3.20 | — | — |
Q3 2023 | Aug 4, 2023 | — | $-4.00 | — | — |
Q2 2023 | May 9, 2023 | — | $-5.20 | — | — |
Q1 2023 | Mar 17, 2023 | $0.08 | $-4.00 | -5100.0% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | — | $-3.20 | — | — |
Q3 2022 | Aug 12, 2022 | — | $-3.20 | — | — |
Q2 2022 | May 13, 2022 | — | $-3.20 | — | — |
Q1 2022 | Mar 23, 2022 | $-0.04 | $-0.12 | -192.5% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | — | $-3.57 | — | — |
Q3 2021 | Aug 30, 2021 | — | $-2.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-11.63 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-1.27 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-1.55 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-1.28 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-4.50 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-4.48 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-5.46 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-6.39 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-1.50 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SQL
What is SQL's current stock price?
SeqLL Inc. (SQL) is currently trading at $6.60 per share. The stock has moved -2.38% today.
What is the analyst price target for SQL?
No analyst price targets are currently available for this stock.
What sector is SeqLL Inc. in?
SeqLL Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is SQL's market cap?
SeqLL Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does SQL pay dividends?
No, SeqLL Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPDN
Applied DNA Sciences, Inc.
$5.62
Mkt Cap: $0.0B
ATNX
Athenex, Inc.
$0.20
Mkt Cap: $0.0B
AWH
Aspira Women's Health Inc.
$0.08
Mkt Cap: $0.0B
BPTS
Biophytis S.A.
$8.22
Mkt Cap: $0.0B
EIGRQ
Eiger BioPharmaceuticals, Inc.
$8.50
Mkt Cap: $0.0B
HIND
Vyome Holdings, Inc.
$3.68
Mkt Cap: $0.0B
NOVN
Novan, Inc.
$0.09
Mkt Cap: $0.0B
NTBL
Notable Labs, Ltd.
$0.25
Mkt Cap: $0.0B
PLXP
PLx Pharma Inc.
$0.09
Mkt Cap: $0.0B
PTN
Palatin Technologies, Inc.
$17.05
Mkt Cap: $0.4B
Explore stocks similar to SQL for comparison